Blockade of SIRPα-CD47 axis by anti-SIRPα antibody enhances anti-tumor activity of DXd antibody-drug conjugates.
Sue M, Tsubaki T, Ishimoto Y, Hayashi S, Ishida S, Otsuka T, Isumi Y, Kawase Y, Yamaguchi J, Nakada T, Ishiguro J, Nakamura K, Kawaida R, Ohtsuka T, Wada T, Agatsuma T, Kawasaki N.
Sue M, et al. Among authors: isumi y.
PLoS One. 2024 Jun 6;19(6):e0304985. doi: 10.1371/journal.pone.0304985. eCollection 2024.
PLoS One. 2024.
PMID: 38843278
Free PMC article.